Dong Wan Kim

Dong Wan Kim

Seoul National University - Seoul / South Korea
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 340455
서울대학교
person_outline Dong Wan Kim's MOST POPULAR ARTICLES
1-) Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trialRS Herbst, P Baas, DW Kim, E Felip, JL Pérez-Gracia, JY Han, J Molina, ...The Lancet 387 (10027), 1540-1550, 201655842016
2-) The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancerP Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...Journal of Thoracic Oncology 11 (1), 39-51, 201640662016
3-) Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung CancerAT Shaw, DW Kim, K Nakagawa, T Seto, L Crinó, MJ Ahn, T De Pas, ...New England Journal of Medicine 368 (25), 2385-2394, 201340482013
4-) First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung CancerBJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...New England Journal of Medicine 371 (23), 2167-2177, 201437232014
5-) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 …B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ...The Lancet 398 (10304), 957-980, 202127512021